Clinical Progress in Mesenchymal Stem Cell Therapy: A Focus on Rheumatic Diseases
ABSTRACT Background Rheumatic diseases are chronic immune‐mediated disorders affecting multiple organ systems and significantly impairing patients' quality of life. Current treatments primarily provide symptomatic relief without offering a cure. Mesenchymal stem cells (MSCs) have emerged as a p...
Saved in:
| Main Authors: | Helal F. Hetta, Alaa Elsaghir, Victor Coll Sijercic, Abdulrahman K. Ahmed, Sayed A. Gad, Mahlet S. Zeleke, Fawaz E. Alanazi, Yasmin N. Ramadan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.70189 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?
by: Carlos Rangel-Peláez, et al.
Published: (2024-12-01) -
Sarcopenia in Rheumatic Diseases: A Hidden Issue of Concern
by: Eleni C. Pardali, et al.
Published: (2025-04-01) -
IMMUNOINFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TYPE I INTERFERON: NEW EVIDENCE
by: E. L. Nasonov, et al.
Published: (2019-09-01) -
Risk factors for severe COVID-19 in patients with rheumatic diseases
by: A. N. Kulikov, et al.
Published: (2024-03-01) -
According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
by: T. V. Popkova, et al.
Published: (2019-11-01)